Results 271 to 280 of about 197,714 (301)
Some of the next articles are maybe not open access.
Best Practice & Research Clinical Rheumatology, 2022
Systemic lupus erythematosus (SLE) is a typical autoimmune disease that leads to multiple organ damage. For over half a century, SLE has been treated mainly with nonspecific glucocorticoids and immunosuppressants, and the development of molecular target drugs with few adverse reactions is awaited.
openaire +2 more sources
Systemic lupus erythematosus (SLE) is a typical autoimmune disease that leads to multiple organ damage. For over half a century, SLE has been treated mainly with nonspecific glucocorticoids and immunosuppressants, and the development of molecular target drugs with few adverse reactions is awaited.
openaire +2 more sources
Baillière's Clinical Rheumatology, 1995
Assessing patients with SLE is difficult because of the heterogeneity of the disease. The Revised 1982 ARA Classification Criteria set has been widely accepted for classifying SLE patients for inclusion in clinical studies, but it is not appropriate for making the diagnosis of SLE in an individual and is not helpful for classifying patients with early ...
openaire +2 more sources
Assessing patients with SLE is difficult because of the heterogeneity of the disease. The Revised 1982 ARA Classification Criteria set has been widely accepted for classifying SLE patients for inclusion in clinical studies, but it is not appropriate for making the diagnosis of SLE in an individual and is not helpful for classifying patients with early ...
openaire +2 more sources
New England Journal of Medicine, 1994
Systemic Lupus Erythematosus (SLE) is defined by its clinical features and by the almost invariable presence in the blood of antibodies directed against one or more components of cell nuclei.
openaire +2 more sources
Systemic Lupus Erythematosus (SLE) is defined by its clinical features and by the almost invariable presence in the blood of antibodies directed against one or more components of cell nuclei.
openaire +2 more sources
Annals of Internal Medicine, 2020
Systemic lupus erythematosus (lupus) is characterized by aberrant activity of the immune system, leading to variable clinical symptoms. Lupus is more prevalent in African American women and women in other ethnic minority groups. Diagnosing, treating, and identifying novel therapies for lupus is challenging because of its genetic and phenotypic ...
Marianthi, Kiriakidou, Cathy Lee, Ching
openaire +2 more sources
Systemic lupus erythematosus (lupus) is characterized by aberrant activity of the immune system, leading to variable clinical symptoms. Lupus is more prevalent in African American women and women in other ethnic minority groups. Diagnosing, treating, and identifying novel therapies for lupus is challenging because of its genetic and phenotypic ...
Marianthi, Kiriakidou, Cathy Lee, Ching
openaire +2 more sources
Hospital Practice, 1979
SLE often presents such a confusing clinical picture that diagnosis is long delayed, and it remains a disease of unknown cause. But early diagnosis and carefully planned therapy can enable many patients to lead nearly normal lives. Recent advances are outlined.
openaire +2 more sources
SLE often presents such a confusing clinical picture that diagnosis is long delayed, and it remains a disease of unknown cause. But early diagnosis and carefully planned therapy can enable many patients to lead nearly normal lives. Recent advances are outlined.
openaire +2 more sources
Journal of the American Academy of Nurse Practitioners, 1998
Carrie B. McCowan, Lorna Schumann
openaire +2 more sources
Carrie B. McCowan, Lorna Schumann
openaire +2 more sources
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Nature Medicine, 2022Fabian Müller +2 more
exaly